Oncology & Cancer

FDA panel backs Glaxo drug for rare sarcoma cancer

(AP) -- A panel of cancer experts overwhelmingly backed the approval of a GlaxoSmithKline drug for a rare type of tumor, noting there are few other treatment options for patients.

Health

Analysis finds government websites downplay PFAS health risks

State and federal public health agencies often understate the scientific evidence surrounding the toxicity of per- and polyfluoroalkyl substances (PFAS) in their public communications, according to an analysis published today ...

Medical research

Microreactor replaces animal testing

Researchers all over Europe are working on alternatives to animal testing that can be used to evaluate the adverse side-effects of medications. But many of these test methods still present problems. A microreactor developed ...

Medications

FDA approves juxtapid for rare cholesterol disorder

(HealthDay)—The U.S. Food and Drug Administration has approved the orphan drug Juxtapid (lomitapide) for patients with homozygous familial hypercholesterolemia (HoFH), for use in combination with a low-fat diet and other ...

Medical research

Liver-simulating device surpasses animal-based alternatives

The HEMIBIO project has developed a Hepatic Microfluidic Bioreactor mimicking the structure of the human liver. The project team is confident that the new device will eventually help remove the need for testing chemicals ...

page 4 from 6